Treatment Supervision and Fidelity Monitoring
TCTSY
ADVERSE EVENTS
The TCTSY facilitators completed standardized session and fidelity notes immediately after each session. Supervision was provided by a cofounder of TCTSY (D.E.) via weekly meetings with the facilitators. These meetings included fidelity feedback between the co-facilitators’ (D.E. and U.A.K.) review of fidelity notes with the TCTSY facilitators, debriefing of each session, and ongoing supervision. One TCTSY facilitator conducted sessions in all 9 cohorts at site 1 and supervised the TCTSY facilitators at site 2 with D.E., enhancing consistency in intervention delivery.For CPT, clinicians maintained fidelity to the 2014 protocolized treatment manual,A data and safety monitoring board was established with the addition of site 2. There were no clinically significant adverse events reported throughout the trial.